kashbiotech

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular options as drug targets and antibody-drug conjugates for remedy

Superior colorectal adenocarcinoma (CRAC), featured by distinctive histopathological look, distant organ metastasis, acquired chemoresistance, and tumorigenic stemness is a bunch of heterogeneous cancers with distinctive genetic signatures and malignant phenotypes. Remedy of CRAC is a daunting exercise for oncologists. In the mean time, quite a few strategies along with molecular specializing in using therapeutic monoclonal…

Read More
kashbiotech

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic

Despite substantial progress in confronting the global HIV-1 epidemic since its inception in the 1980s, better approaches for both treatment and prevention will be necessary to end the epidemic and remain a top public health priority. Antiretroviral therapy (ART) has been effective in extending lives, but at a cost of lifelong adherence to treatment. Broadly…

Read More